Use of low potency estrogens does not reduce the risk of hip fracture (Q43948656)

28 November 2017

title

Use of low potency estrogens does not reduce the risk of hip fracture (English)

1 reference

28 November 2017

1 reference

1

Michaëlsson K

1 reference

28 November 2017

Baron JA

2

1 reference

28 November 2017

Farahmand BY

series ordinal

3

1 reference

28 November 2017

Ljunghall S

series ordinal

4

1 reference

28 November 2017

language of work or name

1 reference

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

30

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

613-618

1 reference

Pictorially assisted recall of past hormone use in case-control studies.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Black-white differences in serum sex hormones and bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Total and free estrogens and androgens in postmenopausal women with hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Estriol: a weak estrogen or a different hormone?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Estriol in the Postmenopause

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Pharmacokinetics of oestrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Bone loss during oestriol therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Estriol production and metabolism in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Oral-contraceptive use and risk of hip fracture: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Women with climacteric symptoms: a target group for prevention of rapid bone loss and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Hormone replacement therapy and major risk factors for reproductive cancers, osteoporosis, and cardiovascular diseases: evidence of confounding by exposure characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Efficacy and safety of oral estriol for managing postmenopausal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Sex hormone concentrations in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

Low-potency oestrogen and risk of endometrial cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900701-3

7 January 2021

10.1016/S8756-3282(01)00701-3

Identifiers

DOI

1 reference

release_lsyyyzltbjcbxpzeyyh32a7kdq

28 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lsyyyzltbjcbxpzeyyh32a7kdq

24 November 2022

mapped directly with Wikidata item

1 reference